Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes

Published:2007-01 Issue:1 Volume:120 Page:63-71
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Gore Joel M.,Spencer Frederick A.,Goldberg Robert J.,Kennelly Brian M.,Fox Keith A.A.,Allegrone Jeanna,Eagle Kim A.,Anderson Frederick A.,Steg Philippe G.

Publisher

Elsevier BV

Subject

General Medicine

Reference14 articles.

1. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in non prior aspirin users;Cohen;Circulation,1994

2. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease;Cohen;N Engl J Med,1997

3. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction;Antman;Circulation,1999

4. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor;Xiao;Circulation,1998

5. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin;Warkentin;N Engl J Med,1995

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a new score for outcome prediction in patients with heart failure with reduced ejection fraction;Minerva Cardioangiologica;2019-05

2. Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions;Journal of Cardiovascular Medicine;2017-08

3. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study;European Heart Journal: Acute Cardiovascular Care;2014-11-20

4. Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes;JAMA;2013-09-18

5. Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?;Cardiovascular Therapy and Prevention;2011-12-20